LENZ
UNKNOWNLENZ Therapeutics, Inc.
CIK: 0001815776
Buy
(50% confidence)
Last activity: 4 days ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Revenue $19.09M
Net Income -$70.76M
Trend Signals
CEO Buy STRONG
CEO buying activity
4 days ago
CFO Buy STRONG
CFO buying activity
4 days ago
Insider Roster (3 total, 3 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Schimmelpennink Evert B. President, CEO and Secretary | 1 | 0 | $251K | 77,289 shares $692K |
| Chevallard Daniel R. Chief Financial Officer | 1 | 0 | $64K | 12,886 shares $110K |
| George Jeffrey P. DIRECTOR | 1 | 0 | $50K | 5,592 shares $50K |
Recent Transactions
BUY Schimmelpennink Evert B. (President, CEO and Secretary)
28,089 shares @ $8.95
$251K
Mar 27, 2026
Conviction: |
View SEC Filing →
BUY Chevallard Daniel R. (Chief Financial Officer)
7,500 shares @ $8.57
$64K
Mar 27, 2026
Conviction: |
View SEC Filing →
BUY George Jeffrey P. (DIRECTOR)
5,592 shares @ $8.92
$50K
Mar 27, 2026
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.